• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER BIOMET, INC. G7 ACETABULAR SYSTEM VIVACIT-E VITAMIN E HIGHLY CROSSLINKED POLYETHYLENE LINER; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER BIOMET, INC. G7 ACETABULAR SYSTEM VIVACIT-E VITAMIN E HIGHLY CROSSLINKED POLYETHYLENE LINER; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER Back to Search Results
Catalog Number 30103607
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Codes Bone Fracture(s) (1870); Joint Dislocation (2374)
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported by the pmi group that a patient underwent a right hip arthroplasty on an unknown date.Subsequently, the patient is being considered for a pmi product on an unknown day for an unknown reason.X-rays received and reviewed, noting loosening of the acetabular component, subsidence of the femoral component, dislocation of the femoral head, and bone fracture of the acetabulum.Attempts have been made and no further information has been provided.
 
Additional Manufacturer Narrative
(b)(4).D10: item# 110010247; lot# 6630992.Item# 650-1057; lot# 2958797.Item# 650-1068; lot# 2965056.Item# 51-103140; lot# 6626648.No product was returned or pictures provided; visual and dimensional evaluations could not be performed.Dhr was reviewed and no discrepancies relevant to the reported event were found.Radiographs were provided and reviewed by a health care professional.Review of the available records identified the following: acetabuli protrusio of the acetabular component with subsidence of the femoral component and dislocation of the femoral head.Fracture superomedial and anterior acetabulum.A definitive root cause cannot be determined.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G7 ACETABULAR SYSTEM VIVACIT-E VITAMIN E HIGHLY CROSSLINKED POLYETHYLENE LINER
Common Device Name
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER
Manufacturer (Section D)
ZIMMER BIOMET, INC.
1800 w. center st.
warsaw IN 46580
Manufacturer (Section G)
ZIMMER BIOMET, INC.
1800 w. center st.
warsaw IN 46580
Manufacturer Contact
jennifer rapsavage
56 e. bell dr.
warsaw, IN 46582
5745260384
MDR Report Key19116668
Report Number0001822565-2024-00453
Device Sequence Number12687488
Product Code LPH
UDI-Device Identifier00889024519923
UDI-Public(01)00889024519923(17)240630(10)64358597
Combination Product (Y/N)N
Initial Reporter StateKY
Initial Reporter CountryUS
PMA/510(K) Number
K190660
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Distributor
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 04/16/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/30/2024
Device Catalogue Number30103607
Device Lot Number64358597
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/19/2022
Initial Report FDA Received Date04/16/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/10/2019
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
NI
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexMale
-
-